ACSL4 and neoplasm: In pancreatic cancer, exosomal ACSL4 secreted by CAFs promotes polyunsaturated fatty acid metabolism, significantly reducing the sensitivity of tumor cells to chemotherapy drugs such as gemcitabine (27).